Usefulness of the Measurement of Psoas Muscle Volume for Sarcopenia Diagnosis in Patients with Liver Disease
Authors:
- Takushi ManabeTMTakushi Manabe
- Chikara OgawaCOChikara Ogawa
- Kei TakumaKTKei Takuma
- Mai NakaharaMNMai Nakahara
- Kyoko OuraKOKyoko Oura
- Tomoko TadokoroTTTomoko Tadokoro
- Koji FujitaKFKoji Fujita
- Joji TaniJTJoji Tani
- Mitsushige ShibatogeMSMitsushige Shibatoge
- Asahiro MorishitaAMAsahiro Morishita
- Masatoshi KudoMasatoshi Kudo
- Tsutomu MasakiTMTsutomu Masaki
Open Access
- 26 March 2023
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 13 (7) , 1245
Abstract
Computed tomography (CT) is often used in the diagnosis of sarcopenia. In this study, we validated the assessment of sarcopenia by the psoas muscle volume using versatile software. The study involved a retrospective analysis of data from 190 patients with liver disease who underwent grip-strength testing and abdominal pelvic computed tomography. To assess sarcopenia, SYNAPSE 3D was used to obtain the skeletal muscle index, the psoas muscle index (PMI), and the simple method. We also used the recently proposed PMI cutoff values, for which the usefulness has been evaluated (O-PMI). The cutoff value of the psoas muscle volume index (PMVI) was determined using one of the diagnostic methods as the gold standard. All diagnostic methods showed that patients with sarcopenia had shorter survival, with O-PMI having the highest hazard ratio (HR) (HR, 6.12; 95% confidence interval [CI], 2.6–14.41; p < 0.001). Even when sarcopenia could not be diagnosed by O-PMI, low PMVI was associated with shorter survival (HR, 3.53; 95% CI, 1.34–9.32; p = 0.01). PMVI may be useful in the evaluation of sarcopenia, including the identification of poor overall survival in cases that cannot be diagnosed by O-PMI, which is considered more useful than PMI.Keywords
This publication has 57 references indexed in Scilit:
- Development of a simple screening test for sarcopenia in older adultsGeriatrics & Gerontology International, 2014
- Unresectable Hepatocellular Carcinoma: MR Imaging after Intraarterial Therapy. Part I. Identification and Validation of Volumetric Functional Response CriteriaRadiology, 2013
- Unresectable Hepatocellular Carcinoma: MR Imaging after Intraarterial Therapy. Part II. Response Stratification Using Volumetric Functional Criteria after Intraarterial TherapyRadiology, 2013
- Neuroendocrine Liver Metastasis Treated by Using Intraarterial Therapy: Volumetric Functional Imaging Biomarkers of Early Tumor Response and SurvivalRadiology, 2013
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)European Heart Journal, 2012
- Effect of Bioimpedance Body Composition Analysis on Function of Implanted Cardiac DevicesPacing and Clinical Electrophysiology, 2012
- Muscle Wasting Is Associated With Mortality in Patients With CirrhosisClinical Gastroenterology and Hepatology, 2012
- Assessing AdiposityCirculation, 2011
- Sarcopenia: European consensus on definition and diagnosisAge and Ageing, 2010